Adu Subramanian
@plainyogurt21.bsky.social
MD Student, Investor, Builder writing adus.substack.com. Website www.subradata.com,
Still on Twitter @plainyogurt21
Still on Twitter @plainyogurt21
Which stock is this? Let's see if people remember pre covid. Hint in next comment
May 25, 2025 at 11:33 AM
Which stock is this? Let's see if people remember pre covid. Hint in next comment
H/T to one of the BioTwitter goats @biotechElmo.
November 30, 2024 at 2:42 PM
H/T to one of the BioTwitter goats @biotechElmo.
This is what ChatGPT says is the impact and thoughts on marty makary ( I asked to source based on pre September 2024 to avoid recent articles).
All of it is a bit vague but makes sense. Overall, His focus is likely on large companies and transparency.
All of it is a bit vague but makes sense. Overall, His focus is likely on large companies and transparency.
November 23, 2024 at 3:52 AM
This is what ChatGPT says is the impact and thoughts on marty makary ( I asked to source based on pre September 2024 to avoid recent articles).
All of it is a bit vague but makes sense. Overall, His focus is likely on large companies and transparency.
All of it is a bit vague but makes sense. Overall, His focus is likely on large companies and transparency.
$BBIO, Everyone on their toes for the last few hours, Label looks clean with mortality benefit. Now up to execution. Expecting > 30% first line share. Patent issues will weigh on it. Important to note the royalties received on FDA approval to alleviate the cash situation
November 23, 2024 at 12:49 AM
$BBIO, Everyone on their toes for the last few hours, Label looks clean with mortality benefit. Now up to execution. Expecting > 30% first line share. Patent issues will weigh on it. Important to note the royalties received on FDA approval to alleviate the cash situation